IGS-L0301

N/A

Report date: 2024/09/25 17:35:34
NME

Base Information

Drug NameIGS-L0301
Drug Alias NameIGS-L0301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesIgnis Therapeutics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIgnis Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A